Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect

The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes of sudden death and heart failure in young, otherwise healthy, individuals. We conducted genome-wide association studies and multi-trait analyses in HCM (1,733 cases), DCM (5,521 cases) and nine left v...

Full description

Bibliographic Details
Main Authors: Tadros, R, Francis, C, Xu, X, Vermeer, AMC, Harper, AR, Huurman, R, Kelu Bisabu, K, Walsh, R, Hoorntje, ET, Te Rijdt, WP, Buchan, RJ, van Velzen, HG, van Slegtenhorst, MA, Vermeulen, JM, Offerhaus, JA, Bai, W, de Marvao, A, Lahrouchi, N, Beekman, L, Karper, JC, Veldink, JH, Kayvanpour, E, Pantazis, A, Baksi, AJ, Whiffin, N, Mazzarotto, F, Sloane, G, Suzuki, H, Schneider-Luftman, D, Elliott, P, Richard, P, Ader, F, Villard, E, Lichtner, P, Meitinger, T, Tanck, MWT, van Tintelen, JP, Thain, A, McCarty, D, Hegele, RA, Roberts, JD, Amyot, J, Dubé, M-P, Cadrin-Tourigny, J, Giraldeau, G, L'Allier, PL, Garceau, P, Tardif, J-C, Boekholdt, SM, Lumbers, RT, Watkins, H
Format: Journal article
Language:English
Published: Nature Research 2021
_version_ 1826295279858483200
author Tadros, R
Francis, C
Xu, X
Vermeer, AMC
Harper, AR
Huurman, R
Kelu Bisabu, K
Walsh, R
Hoorntje, ET
Te Rijdt, WP
Buchan, RJ
van Velzen, HG
van Slegtenhorst, MA
Vermeulen, JM
Offerhaus, JA
Bai, W
de Marvao, A
Lahrouchi, N
Beekman, L
Karper, JC
Veldink, JH
Kayvanpour, E
Pantazis, A
Baksi, AJ
Whiffin, N
Mazzarotto, F
Sloane, G
Suzuki, H
Schneider-Luftman, D
Elliott, P
Richard, P
Ader, F
Villard, E
Lichtner, P
Meitinger, T
Tanck, MWT
van Tintelen, JP
Thain, A
McCarty, D
Hegele, RA
Roberts, JD
Amyot, J
Dubé, M-P
Cadrin-Tourigny, J
Giraldeau, G
L'Allier, PL
Garceau, P
Tardif, J-C
Boekholdt, SM
Lumbers, RT
Watkins, H
author_facet Tadros, R
Francis, C
Xu, X
Vermeer, AMC
Harper, AR
Huurman, R
Kelu Bisabu, K
Walsh, R
Hoorntje, ET
Te Rijdt, WP
Buchan, RJ
van Velzen, HG
van Slegtenhorst, MA
Vermeulen, JM
Offerhaus, JA
Bai, W
de Marvao, A
Lahrouchi, N
Beekman, L
Karper, JC
Veldink, JH
Kayvanpour, E
Pantazis, A
Baksi, AJ
Whiffin, N
Mazzarotto, F
Sloane, G
Suzuki, H
Schneider-Luftman, D
Elliott, P
Richard, P
Ader, F
Villard, E
Lichtner, P
Meitinger, T
Tanck, MWT
van Tintelen, JP
Thain, A
McCarty, D
Hegele, RA
Roberts, JD
Amyot, J
Dubé, M-P
Cadrin-Tourigny, J
Giraldeau, G
L'Allier, PL
Garceau, P
Tardif, J-C
Boekholdt, SM
Lumbers, RT
Watkins, H
author_sort Tadros, R
collection OXFORD
description The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes of sudden death and heart failure in young, otherwise healthy, individuals. We conducted genome-wide association studies and multi-trait analyses in HCM (1,733 cases), DCM (5,521 cases) and nine left ventricular (LV) traits (19,260 UK Biobank participants with structurally normal hearts). We identified 16 loci associated with HCM, 13 with DCM and 23 with LV traits. We show strong genetic correlations between LV traits and cardiomyopathies, with opposing effects in HCM and DCM. Two-sample Mendelian randomization supports a causal association linking increased LV contractility with HCM risk. A polygenic risk score explains a significant portion of phenotypic variability in carriers of HCM-causing rare variants. Our findings thus provide evidence that polygenic risk score may account for variability in Mendelian diseases. More broadly, we provide insights into how genetic pathways may lead to distinct disorders through opposing genetic effects.
first_indexed 2024-03-07T03:58:35Z
format Journal article
id oxford-uuid:c3ba02f5-a29f-4145-a8b8-d3e86d5db3f0
institution University of Oxford
language English
last_indexed 2024-03-07T03:58:35Z
publishDate 2021
publisher Nature Research
record_format dspace
spelling oxford-uuid:c3ba02f5-a29f-4145-a8b8-d3e86d5db3f02022-03-27T06:18:48ZShared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effectJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c3ba02f5-a29f-4145-a8b8-d3e86d5db3f0EnglishSymplectic ElementsNature Research2021Tadros, RFrancis, CXu, XVermeer, AMCHarper, ARHuurman, RKelu Bisabu, KWalsh, RHoorntje, ETTe Rijdt, WPBuchan, RJvan Velzen, HGvan Slegtenhorst, MAVermeulen, JMOfferhaus, JABai, Wde Marvao, ALahrouchi, NBeekman, LKarper, JCVeldink, JHKayvanpour, EPantazis, ABaksi, AJWhiffin, NMazzarotto, FSloane, GSuzuki, HSchneider-Luftman, DElliott, PRichard, PAder, FVillard, ELichtner, PMeitinger, TTanck, MWTvan Tintelen, JPThain, AMcCarty, DHegele, RARoberts, JDAmyot, JDubé, M-PCadrin-Tourigny, JGiraldeau, GL'Allier, PLGarceau, PTardif, J-CBoekholdt, SMLumbers, RTWatkins, HThe heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes of sudden death and heart failure in young, otherwise healthy, individuals. We conducted genome-wide association studies and multi-trait analyses in HCM (1,733 cases), DCM (5,521 cases) and nine left ventricular (LV) traits (19,260 UK Biobank participants with structurally normal hearts). We identified 16 loci associated with HCM, 13 with DCM and 23 with LV traits. We show strong genetic correlations between LV traits and cardiomyopathies, with opposing effects in HCM and DCM. Two-sample Mendelian randomization supports a causal association linking increased LV contractility with HCM risk. A polygenic risk score explains a significant portion of phenotypic variability in carriers of HCM-causing rare variants. Our findings thus provide evidence that polygenic risk score may account for variability in Mendelian diseases. More broadly, we provide insights into how genetic pathways may lead to distinct disorders through opposing genetic effects.
spellingShingle Tadros, R
Francis, C
Xu, X
Vermeer, AMC
Harper, AR
Huurman, R
Kelu Bisabu, K
Walsh, R
Hoorntje, ET
Te Rijdt, WP
Buchan, RJ
van Velzen, HG
van Slegtenhorst, MA
Vermeulen, JM
Offerhaus, JA
Bai, W
de Marvao, A
Lahrouchi, N
Beekman, L
Karper, JC
Veldink, JH
Kayvanpour, E
Pantazis, A
Baksi, AJ
Whiffin, N
Mazzarotto, F
Sloane, G
Suzuki, H
Schneider-Luftman, D
Elliott, P
Richard, P
Ader, F
Villard, E
Lichtner, P
Meitinger, T
Tanck, MWT
van Tintelen, JP
Thain, A
McCarty, D
Hegele, RA
Roberts, JD
Amyot, J
Dubé, M-P
Cadrin-Tourigny, J
Giraldeau, G
L'Allier, PL
Garceau, P
Tardif, J-C
Boekholdt, SM
Lumbers, RT
Watkins, H
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
title Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
title_full Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
title_fullStr Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
title_full_unstemmed Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
title_short Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
title_sort shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
work_keys_str_mv AT tadrosr sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT francisc sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT xux sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT vermeeramc sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT harperar sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT huurmanr sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT kelubisabuk sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT walshr sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT hoorntjeet sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT terijdtwp sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT buchanrj sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT vanvelzenhg sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT vanslegtenhorstma sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT vermeulenjm sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT offerhausja sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT baiw sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT demarvaoa sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT lahrouchin sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT beekmanl sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT karperjc sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT veldinkjh sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT kayvanpoure sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT pantazisa sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT baksiaj sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT whiffinn sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT mazzarottof sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT sloaneg sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT suzukih sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT schneiderluftmand sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT elliottp sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT richardp sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT aderf sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT villarde sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT lichtnerp sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT meitingert sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT tanckmwt sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT vantintelenjp sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT thaina sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT mccartyd sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT hegelera sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT robertsjd sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT amyotj sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT dubemp sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT cadrintourignyj sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT giraldeaug sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT lallierpl sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT garceaup sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT tardifjc sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT boekholdtsm sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT lumbersrt sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect
AT watkinsh sharedgeneticpathwayscontributetoriskofhypertrophicanddilatedcardiomyopathieswithoppositedirectionsofeffect